SE437157B - 1-(4-amino-6,7-dimetoxi-2-kinazolinyl)-4-(2-tetrahydrofuroyl)piperazinhydroklorid-dihydrat och farmaceutisk komposition - Google Patents
1-(4-amino-6,7-dimetoxi-2-kinazolinyl)-4-(2-tetrahydrofuroyl)piperazinhydroklorid-dihydrat och farmaceutisk kompositionInfo
- Publication number
- SE437157B SE437157B SE7808316A SE7808316A SE437157B SE 437157 B SE437157 B SE 437157B SE 7808316 A SE7808316 A SE 7808316A SE 7808316 A SE7808316 A SE 7808316A SE 437157 B SE437157 B SE 437157B
- Authority
- SE
- Sweden
- Prior art keywords
- compound
- amino
- dimethoxy
- quinazolinyl
- piperazine hydrochloride
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82167577A | 1977-08-04 | 1977-08-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7808316L SE7808316L (sv) | 1979-02-05 |
| SE437157B true SE437157B (sv) | 1985-02-11 |
Family
ID=25234014
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7808316A SE437157B (sv) | 1977-08-04 | 1978-08-01 | 1-(4-amino-6,7-dimetoxi-2-kinazolinyl)-4-(2-tetrahydrofuroyl)piperazinhydroklorid-dihydrat och farmaceutisk komposition |
| SE8400042A SE455373B (sv) | 1977-08-04 | 1984-01-04 | Anvendning av 1-(4-amino-6,7-dimetoxi-2-kinazolinyl)-4-(2-tetrahydrofuroyl)piperazinhydroklorid-dihydrat for framstellning av ett lekemedel |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8400042A SE455373B (sv) | 1977-08-04 | 1984-01-04 | Anvendning av 1-(4-amino-6,7-dimetoxi-2-kinazolinyl)-4-(2-tetrahydrofuroyl)piperazinhydroklorid-dihydrat for framstellning av ett lekemedel |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPS63211229A (ja) |
| MX (1) | MX5483E (ja) |
| PH (1) | PH15619A (ja) |
| SE (2) | SE437157B (ja) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4092315A (en) * | 1976-03-01 | 1978-05-30 | Pfizer Inc. | Novel crystalline forms of prazosin hydrochloride |
-
1978
- 1978-07-03 MX MX787204U patent/MX5483E/es unknown
- 1978-07-24 PH PH21415A patent/PH15619A/en unknown
- 1978-08-01 SE SE7808316A patent/SE437157B/sv not_active IP Right Cessation
-
1984
- 1984-01-04 SE SE8400042A patent/SE455373B/sv not_active IP Right Cessation
-
1987
- 1987-12-28 JP JP62330314A patent/JPS63211229A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| SE8400042L (sv) | 1984-01-04 |
| SE7808316L (sv) | 1979-02-05 |
| SE455373B (sv) | 1988-07-11 |
| JPS63211229A (ja) | 1988-09-02 |
| SE8400042D0 (sv) | 1984-01-04 |
| MX5483E (es) | 1983-08-23 |
| JPH0259127B2 (ja) | 1990-12-11 |
| PH15619A (en) | 1983-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1081229A (en) | 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl) piperazine hydrochloride dihydrate | |
| US4161595A (en) | Levulinic acid salt | |
| HU224212B1 (hu) | 5-[4-[2-(N-metil-N-(2-piridil)amino)etoxi]benzil]tiazolidin-2,4-dion-maleát és ezt tartalmazó gyógyszerkészítmények | |
| DK175313B1 (da) | Farmaceutisk middel indeholdende 1-[mono- eller bis(trifluormethyl)-2-pyridinyl]piperaziner | |
| US11345706B2 (en) | Crystalline forms of Acalabrutinib | |
| US5391552A (en) | Diphenylpiperazine derivative and drug for circulatory organ containing the same | |
| US20020147195A1 (en) | Piperidine derivatives and anti-platelet agents containing the same | |
| EA014101B1 (ru) | Антагонист cd80 | |
| JPS5827796B2 (ja) | テオフイリニルメチルジオキソラン誘導体およびその製法 | |
| SE437157B (sv) | 1-(4-amino-6,7-dimetoxi-2-kinazolinyl)-4-(2-tetrahydrofuroyl)piperazinhydroklorid-dihydrat och farmaceutisk komposition | |
| CZ295819B6 (cs) | Krystalická polymorfní forma A (2S, 3S)-N-(methoxy-5-terc-butylfenyl)methyl-2-difenylmethyl-1-azabicyklo[2.2.2]oktan-3-amin citrátu monohydrátu, způsob její přípravy a použití a farmaceutická kompozice s jejím obsahem | |
| CA1098447A (en) | 2-.gamma.-(PIPERIDINO)-PROPYL-1,2-BENZISOTHIAZOL-3-ONE | |
| KR20200039838A (ko) | 페닐아미노피리미딘 화합물 또는 이의 염의 다형체 | |
| JP2962186B2 (ja) | ピペリジン誘導体及びそれを含有するセロトニン拮抗薬 | |
| HU191637B (en) | Process for producing piperidine derivatives | |
| EP0017352A2 (en) | Chromanone derivatives, a process for their preparation, compositions containing them | |
| US6452007B1 (en) | Crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine | |
| US6706705B1 (en) | Quinazoline derivatives | |
| US11667656B2 (en) | Crystalline forms of Tenofovir alafenamide | |
| US3833578A (en) | Pyrazinoylalkylbenzenesulfonylureas and process for their preparation | |
| US10611772B2 (en) | Crystalline form of Ribociclib succinate | |
| US6242466B1 (en) | Substituted phenylamidines | |
| JPH09118618A (ja) | Ｎ，ｎ−ジエチル−８，８−ジプロピル−２−アザスピロ［４．５］デカン−２−プロパンアミン・二マレイン酸塩 | |
| HU193079B (en) | Process for producing 3-alkoxy-2-pyrrolidino-n-pyrimidinyl-or -n-pyrazinyl-propyl-amines and pharmaceutical compositions containing them as active agents | |
| EP0187639A1 (en) | Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SPCF | Application for supplementary protection certificate filed |
Free format text: 7808316 |
|
| NAL | Patent in force |
Ref document number: 7808316-9 |
|
| SPCG | Supplementary protection certificate granted |
Free format text: 9490111, 891208, EXPIRES: 20030801 |
|
| NUG | Patent has lapsed |
Ref document number: 7808316-9 |